Cargando…
Fatty Liver Disease in HIV: Predictors and Response to Statin Therapy
BACKGROUND: Liver disease has emerged as a leading cause of mortality and morbidity in HIV. Much of the current challenge in liver disease is related to nonalcoholic fatty liver disease (NAFLD). In HIV-uninfected populations, statin therapy has been suggested as potential intervention, but no such d...
Autores principales: | El Kamari, Vanessa, Hileman, Corrilynn O, Mccomsey, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632206/ http://dx.doi.org/10.1093/ofid/ofx162.136 |
Ejemplares similares
-
1573 Use of protease inhibitors is associated with higher selenium levels in treated HIV infection
por: Kumar, Jessica, et al.
Publicado: (2014) -
Impact of Heroin and HIV on Gut Integrity and Immune Activation
por: Hileman, Corrilynn O., et al.
Publicado: (2022) -
Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control
por: Mouchati, Christian, et al.
Publicado: (2022) -
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV
por: Webel, Allison R., et al.
Publicado: (2020) -
933. Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated HIV Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)